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Abstract
Background: Literature shows that not only are traffic injuries due to accidents, but that there is also a correlation
between different chronic conditions, the consumption of certain types of drugs, the intake of psychoactive
substances and the self perception of risk (Health Belief Model) and the impact/incidence of traffic accidents. There
are few studies on these aspects in primary health care.
The objectives of our study are:
Main aim: To outline the distribution of risk factors associated with Road Traffic Injuries (RTI) in a driving population
assigned to a group of primary health care centres in Barcelona province.
Secondly, we aim to study the distribution of diverse risk factors related to the possibility of suffering an RTI
according to age, sex and population groups, to assess the relationship between these same risk factors and self
risk perception for suffering an RTI, and to outline the association between the number of risk factors and the
history of reported collisions.
Methods/Design: Design: Cross-sectional, multicentre study.
Setting: 25 urban health care centres.
Study population: Randomly selected sample of Spanish/Catalan speakers age 16 or above with a medical register
in any of the 25 participating primary health care centres. N = 1540.
Unit of study: Basic unit of care, consisting of a general practitioner and a nurse, both of whom caring for the
same population (1,500 to 2,000 people per unit).
Instruments of measurement: Data collection will be performed using a survey carried out by health professionals,
who will use the clinical registers and the information reported by the patient during the visit to collect the base-
line data: illnesses, medication intake, alcohol and psychoactive consumption, and self perception of risk.
Discussion: We expect to obtain a risk profile of the subjects in relation to RTI in the primary health care field, and
to create a group for a prospective follow-up.
Trial Registration: Clinical Trials.gov Identifier: NCT00778440.
Background
Traffic injuries are serious health problems that cause
death, morbidity and disability, as well as an important
impact on a country’s economy [1]. There are three high
risk groups: 15-24 years old who use mopeds or motor-
bikes, 18-34 years old driving as tourists, and over 65 years
old pedestrians in urban areas. According to the last
Catalan Health Survey (Enquesta de Salut a Catalunya
ESCA) in 2006, 17.8% of those over 15 years of age had
been injured in a road traffic accident (RTI) in the last
year, 6.75% of whom had been injured in a road traffic col-
lision in the previous two weeks. Figures for men were
higher at 9.33% than for women at 4.33%. There were also
differences in age with 8.05% aged between 15 and 44,
5.04% aged between 45 and 64 and 15.5% aged over 65 [2].
RTI are not coincidental, but they adhere to foresee-
able factors. Medication and chronic conditions, despite
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some cases [3-5]. Usually, when we talk about impli-
cated factors in RTI, four groups can be considered:
human factors, aspects related to the vehicle, aspects
related to the collision environment (traffic, lane, etc)
and socio-economic aspects [6,7].
The alcohol consumption factor on its own is the big-
gest contributor to the production of serious RTIs. The
use of certain types of medication and psychoactive sub-
stances may alter the driving capacity as well [8]. In our
field, between 5% and 15% of drivers killed in an acci-
dent show significant blood levels of other psychoactive
substances (including or not including alcohol) [9].
There have also been international studies which have
proven the existence of a relationship between psy-
choactive substances like benzodiazepines [10,11], can-
nabis and cocaine [12,13].
As for health problems, the previous morbidity of the
driver is considered to be a possible accident inducing
factor, and some chronic health problems like diabetes
mellitus, epilepsy, hearing or visual impairments, cogni-
tive deteriorations and some psychiatric disorders have
been associated with RTI. Despite this, the illness-acci-
dent relationship is not easy to consider objectively due
to methodological difficulties [14].
Drugs and psychoactive substances
According to the 2006 Catalan Health Survey
(ESCA’06), 21.7% of the Catalan population take some
kind of medication, 69.5% of which is prescribed by a
doctor, 5.5% prescribed by a pharmacist and 25% is self-
medicated. Table 1 shows the available data on the con-
sumption of certain medication which can affect driving
capacities in the general population of Catalonia [2].
In a study carried out on the Spanish driving popula-
tion killed in a traffic accident in 1992, 45% had been
taking some kind of medication during the previous
year, 17% of which were taken regularly [15].
On the other hand, a study which included 8,000
Spanish drivers showed that an estimated 10% of those
k i l l e do ri n j u r e di nat r a f f i c collision had taken some
kind of psychoactive substance. Moreover, an analysis
by the National Toxicology Institute (Instituto Nacional
de Toxicología) during the period between 1991 and
1999 showed that in 4.382 drivers killed on the road,
54% had taken some kind of psychoactive substance and
5% had been on medication [16,17]. Finally, a recent
study, performed in Catalonia, which assessed subjects
who had been injured in a traffic accident, observed a
high prevalence of consumption of psychoactive sub-
stances, especially alcohol, cannabis and cocaine, which
was relevant in all age groups [18].
Several review papers underline the effect of certain
drugs on driving capacity such as narcoleptics or anti-
psychotics, anxyolitics, sedatives and hypnotics, tricycle
antidepressants, lithium, (narcotic and non narcotic)
analgesics and anti-migraine agents, anaesthetics, antie-
pileptic drugs, non steroid anti-inflammatory drugs,
mio-relaxing agents, anti-Parkinson drugs, H1-antihista-
mines, anticolinergics and some cardiovascular drugs
[19,20].
A recently published review paper suggests the need
for research on the role of medication in road safety
(other than the use of benzodiazepines, which has
already been widely studied) [21], and the need to inves-
tigate more on the side effects of different drugs when
driving [22].
In Spain, the cautionary information about the effect of
drugs on driving capacities is ruled by Royal Law (Real
Decreto) 1345/2007 [23], which newly includes a picto-
gram for any medication that can alter driving ability or
the ability to use dangerous machinery. This information
is currently being reviewed and classified according to
the ICADTS (International Council on Alcohol, Drugs
and Traffic Safety) categories, shown in Table 2. These
take into consideration 3 groups according to the alcohol
intake amounts considered safe, risky or not recom-
mended. Currently, 424 active principles have been
reviewed, which will lead to a change in 2,633 medicine
labels by 2011, as in other eleven EU countries [24].
The European Union has also dealt with problems
related to medication and driving, particularly in an
international project named “The Integrated Project
DRUID (Driving Under the Influence of Drugs, Alcohol
and Medicines)”, which analyses the effect that the
intake of medicines, medicinal herbs and psychoactive
substances can have on road safety [25].
Chronic health conditions
Until the 1960’s, the correlation between chronic health
problems and road traffic injuries was very controversial.
Different groups of researchers started to observe a cor-
relation between collisions and injuries suffered by dri-
vers with diabetes, epilepsy, cardiovascular illnesses,
alcoholism and mental disorders [26].
Table 1 Consumption of certain drugs in the general
population of Catalonia
Pharmacological
Group
General
population (%)
Men
(%)
Women
(%)
Anxyolitics 9,1 5,72 12,38
Antidepressants 6,8 3,73 9,77
Antihistamines 3,18 2,44 3,89
Hypnotics 7,32 4,02 10,62
Antiepileptic drugs 0,3 0,28 0,30
Antiparkinsonian agents
(>65 yrs)
0,76 0,6 0,8
ESCA’06
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that diverse long-term conditions and age, elements that
usually go together, can have on the incidence of RTIs
[27].
The Catalan Accident Statistics Annual Report (2003)
indicates that in 7.6% of the collisions with victims, dri-
vers suffered from the sudden appearance of an illness
[28]. This same observation has been suggested at an
international level [29]. According to data obtained from
diverse review papers [30-33], a risk table has been pub-
lished for different health problems and their adjusted
risk, if the correct treatment was carried out. The fol-
lowing findings should be noted: the relative risk of a
driver with a chronic health condition of suffering a
traffic injury is 1.33 (IC95% 1.28-1.37); the most highly
associated illnesses are: Sleep Apnea Syndrome [RR 3.71
(IC95% 2.14-6.4)], neurological conditions [RR 1.75
(IC95% 1.61-1.89)], arthritis/joint limitations [RR 1.17
(IC95% 1.004-1.36)], cardio-vascular illnesses [RR 1.23
(IC95% 1.09-1.38)], diabetes mellitus [RR 1.56 (IC95%
1.31-1.86)], mental disorders [RR 1.72 (IC95% 1.48-
1.99)], visual impairments [RR 1.09 (IC95% 1.04-1.15)],
hearing impairments [RR 1.19 (IC95% 1.02-1.4)] and
high alcohol consumption [RR 2.00 (IC95% 1.89-2.12)]
[30].; and the risks for the population with chronic
health problems diminish in general if they are being
treated and adequately controlled, with the exception of
some chronic health problems where the risk can
increase through the use of different types of medication
(e.g. benzodiazepines) [31,34].
The situation in Primary Care
In our country, few articles have been published on RTI
and their impact in Primary Health care. Most of them,
written during the 1990’s have consisted of descriptive
epidemiological studies on the impact of road traffic
injuries on the number of emergency consultations, its
prevalence according to age groups and gender and stu-
dies on time, place and gravity of the RTI. If sum-
marised, they show that the frequency of RTI is
approximately 8 per 1,000 inhabitants [35,36] making up
4.1% of all consultations in a primary health care centre
[37]. Of all collision accidents of any kind, those on a
public road are the second most frequent, after domestic
accidents, road traffic injuries making up between 8.3%
and 8.6% of all kinds [37-39].
The most serious RTI happen on the road, and affect
male drivers more (approximately 70%), with an average
age of 27 ± 3 years [35-37], with a large peak in the
group around 20 ± 5 years of age (42.8% of cases) [36].
The impact makes up 1% of the total of patients
attended in an emergency centre [40].
Diverse authors warn of the high occurrence of RTI in
children (245 per 1,000 inhabitants) [38], and the impor-
tance of the use of child protection methods in vehicles.
20.75% of child accidents correspond to the RTI that
affect those aged 12 ± 2 years [41,42].
The Theory of Change model and risk of RTI
There are different theoretical explanations which try to
predict the change in the prevention behaviour of popu-
lations. Of all the analysed theories [43], the so called
Health Belief Model shows that the most important ele-
ments are: risk perceptions (personal susceptibility to
suffer an injury), capacity to carry out effective activities
and their economic costs.
Several studies have aimed at describing the risk per-
ception in relation to risky driving behaviours [44], cul-
tural differences [45], the use of mobile phones while
driving [46], the position of hands when driving [47].
Diverse population groups have also been studied such
as young drivers compared to older drivers [48]. Others
have examined differences in the perception of traffic
risks for older and younger adults [49]. Also, the percep-
tion of risk has been studied in relation to training [50],
age and driving expertise [51]. These have been particu-
larly assessed amongst drivers under the effects of alco-
hol [52,53]. Just a few studies have established the
existing relationship between health conditions and risk
perception; amongst them, we found some papers on
risk perception in diabetic patients during hypoglycae-
mic stages [54,55], and in epileptic subjects [56].
Available publications show several methods to mea-
sure the risk perception for an RTI. Likert scales with
closed questions and a scale between complete disagree-
ment to complete agreement have been used in some
cases [47], as well as multiple-choice questionnaires
(measuring probability of traffic accidents, consequences
of traffic accidents, risk sensitivity and risk willingness
with Likert scales) [45]. In some studies, the risk asso-
ciated to particular traffic conditions and driving beha-
viours was assessed [50] and in others it was analysed
Table 2 ICADTS classification of drugs in terms of driving effects
CATEGORY DESCRIPTION BAC (g/l) ADVISE TO THE PATIENT
I Presumed safe or unlikely effect < 0,5 Read the patient information leaflet before driving.
II Likely minor or moderate effect 0,5 - 0,8 Do not drive without consulting a health professional.
III Likely severe effect or presumed dangerous > 0,8 Do not drive while you are taking this medicine.
BAC: Blood Alcohol Concentration (g/l) equivalence.
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high risk [44]
Justification For The Study
The available research in this field has been revised and
a consensus that included recommendations to carry
out epidemiological studies in different areas provided.
Given the current situation, studies that inform us of
the situation at a level closest to the patient (primary
health care) are essential. As are studies that permit us
to set out risk levels based on a description of exposi-
tion to drugs, riskful behaviour (alcohol intake and con-
sumption of other psychoactive substances) and chronic
and acute health conditions,a n ds t u d i e st h a ta s s e s st h e
RTI risk perception of drivers.
On the other hand, the prospective group follow-up
can give us an idea of the changes that may appear in
terms of RTI risk factors, and in terms of traffic colli-
sions with/without injuries. Without a doubt, this is use-
ful information in the planning of preventative
interventions in primary health care.
Objectives
Main aim: to assess the distribution of the risk factors
associated with RTI in a driving population assigned to
a group of participating primary health care centres in
the city of Barcelona.
Secondary objectives: 1. To study the distribution of
RTI risk factors relative to medications, illnesses, alcohol
intake and/or consumption of psychoactive substances in
the driving population in different groups according to
age and gender. 2. To outline the correlation between the
number of risk factors related to suffering an RTI and
the background of registered collisions, having or not
having recieved medical attention. 3. To assess the exist-
ing relationship between the self perception level of risk
of RTI and the presence of chronic health conditions,
medication or consumption of psychoactive substances.
Methods/Design
Study design
Cross-sectional and multicentre study.
Setting
25 primary health care centres in Barcelona.
Study population
Drivers aged 16 or above who have been attended and
who have a clinical register at the participating primary
health care centres.
Sample size calculation
The calculation was carried out using the population of
men and women with a driving license in the Barcelona
province from the age 16 and over, according to the
2005 census of drivers made available by the General
Traffic Department (DGT). For sample calculation pur-
poses, four age groups proportional to women and men
were created. Accepting an alpha risk of 0.05 with a
precision of +/- 0.05 percentage units in a bilateral con-
trast for an estimated proportion of 0.5, a random
population sample of 385 subjects was determined for
each age group. The total sample size is 1540 subjects
(Table 3).
Recruitment Process
The study population will be recruited by consecutive
sampling. Each collaborating researcher, after verifying
the inclusion criteria, will include 16 subjects, two for
every age and gender group of those described in the
table above. All subjects of 16 years of age or over that
consult any collaborating health professionals (nurses or
doctors) for any motive, will be invited to participate.
They will be informed by the collaborating researcher
(patient information leaflet) and asked to take part in
the study and in yearly follow-ups via telephone. In case
of acceptance, they will read and sign a consent form.
Each centre will recruit patients until reaching the num-
ber of participants stipulated, taking into account the
necessary distribution by age groups and sex. Figure 1
Flow Chart: Algorithm of the study shows the recruit-
ment system and yearly monitoring.
Selection criteria
Inclusion criteria
aged 16 or above; sufficient understanding and knowl-
edge of Catalan or Spanish; possession of valid driving
or motorbike license; subject’s agreement to participate
in the study and in yearly follow ups via telephone
through a signed consent form.
Exclusion criteria
people who do not poses a telephone contact number;
those with serious psychiatric problems; those with phy-
sical or psychiatric disabilities that impede their partici-
pation in the study; those with a terminal illness.
All centres of Barcelona province and the metropoli-
tan area will be invited to participate, and those who
voluntarily accept to participate will be included in the
study. To date, at the end of the recruitment period, 25
practices will participate in the study.
Table 3 Sample size according to the estimated
distribution in age and gender groups
16-24 yrs 25-34 yrs 35-64 yrs Above 74 yrs Total
Men 214 212 228 317 971
Women 171 173 157 68 569
Total 385 385 385 385 1540
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In the inclusion visit, the health professional will gather
the relevant medical data and history (illnesses, medica-
tion, alcohol consumption and psychoactive substances)
from the patient’s clinical record, after checking and
completing it together with the patient. Then, relevant
data on behaviour and risk-perception of suffering from
an RTI, and data on previous traffic accidents will be
collected.
A yearly follow up via telephone is expected to be
performed.
Study variables
We dispose of two data collection instruments in order to
carry out this study
-A survey, which will be carried out by health profes-
sionals in a face to face interview. Data will be obtained
from the clinical register, and double-checked by the
researcher and patient during the visit.
In this survey, the following will be noted: 1. Demo-
graphic data: age, gender, civil status, place of origin,
level of studies, social class (according to the categories
proposed by the Spanish Epidemiology Society). 2. Med-
ication: long-term medication, acute medication (taken
in the last 30 days). 3. Chronic health conditions related
to higher risk of RTI (Table 3). 4. Alcohol consumption
(measured using the AUDIT-C test). 5. Consumption of
psychoactive substances (cocaine, ecstasy and others)
during the last year, as self-reported by the patient and
self-declared dependency level of psychoactive sub-
stances in the last month. 6. Estimated level of percep-
tion risk, as assessed by the health professional, and
rated using a scale from 0 (no risk) to 10 (maximum
risk). 7. Driving data: type of driver’s license, length of
time driver’s license held; type of vehicle most usually
driven (moped, motorbike, car, others); professional dri-
ver (y/n); time spent driving in hours per week; type of
road usually used (urban, motorway or others); safety
behaviours (use of seatbelts, use of helmet, use of car
seats for children and adherence to speed limits). 8. Col-
lision background in the last year (with or without
injury); History of medical attention for traffic road inju-
ries in the last year. 9. Self-declared self medicating. 10.
Self evaluation of state of health (using the SF-12 test).
11. Self-perception of risk. Individuals will be asked to
score their own risk for RTIs, when compared to sub-
jects with their same gender and age, rated in a scale
from 0 to 10.
-Telephone survey: In the telephone survey carried out
annually by a trained interviewer the following data will
be collected and reviewed: 1. Collisions in the last year:
date, time of day and day of the week when it occurred;
type of road where the collision occurred; vehicle being
driven and other vehicles implicated in the crash; medical
attention needed (Yes/No/type); need for a sick leave due
to traffic injuries (Yes/No/duration); after-effects (Yes/
No/type); approximate material costs/vehicle repairs
needed (Yes/No/Costs). 2. Newly diagnosed long-term
conditions (in the last year). 3. Chronic and acute medi-
cation recently taken (time taken and coded according to
therapeutic risk group). 4. Self-reported consumption of
psychoactive substances. 5. Changes in driving condi-
tions: type of vehicle usually driven, time spent driving in
hours per week; type of road usually used (urban, motor-
way or others); safety behaviour (use of seatbelts, use of
helmet, use of car seats for children and adherence to
speed limits). 6. Changes in level of self-perception of
risk (as reported by the subject of study).
Statistical analysis
The characteristics of the population will be outlined
using a descriptive univariant analysis, calculating the
average, standard deviation, median, minimum and max-
imum values for continuous variables, and frequency
and percentages for categorical variables.
The results of the descriptive part will be expressed
with their confidence interval (CI 95%). In order to
investigate the distribution of the risk factors associated
with suffering an RTI according to age and gender,
bivariant comparisons will be carried out using the Chi-
square test between categorical variables and the
Figure 1 Flow Chart: Algorithm of the study.
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ables. In order to analyse the association between the
risk perception of an RTI (low/medium/high) and the
different risk factors considered, an unconditional binary
logistical regression model will be implemented. For the
risk perception considered as an ordinal scale, a multiple
lineal regression will be implemented. For the selection
of the variables for the multivariate model, the metho-
dology proposed by Hosmer-Memeshow [57], Cobo [58]
and Greenland [59] will be implemented. In the initial
multivariate model, the significant bivariate level vari-
ables will be introduced, based on the level of signifi-
cance p = 0.25 and the variables considered to be
clinically relevant. Confusion, interaction and co-linear-
ity factors will be analysed. The adjustment of the
model will be evaluated using the Hosmer-Lemeshow
test and the area under the curve.
All statistical tests will be carried out with a confi-
dence level of 95% and supposing a bilateral contrast.
The analyses with be carried out using the statistics
package SPSS.
Quality control
The variables collected during the interview with the
health professional will be reviewed and checked against
the patient’s clinical record during the same visit. Coor-
dination meetings will be held with the collaborating
researchers periodically. Any confusing or missing data
will be revised by one of the investigators who will ask
for explanations from the relevant investigator. Data col-
lection booklets will be read using Teleform technology.
The introduction of the data into the database as well as
quality control will be carried out by a trained person
with ample experience using Teleform. The interviewers
carrying out the telephone interview will be trained and
accredited periodically in order to ensure the maximum
quality of data collection.
Difficulties and limitations of the study
In this study the relationship of risk factors of suffering
an RTI will be evaluated; however, this does not apply
to causality assessment, which would need a different
specific study design.
There may be subjects who, although are assigned to
one of the participating centres, do not have an open
clinical register there because it is the first time they
have visited the clinic or because the record is on paper.
In these cases, the clinical data will be collected during
the inclusion visit.
The computerised clinical registers (eCAP™ software
or similar) may not be correctly updated in some cases,
due to their recent addition to the clinic. The research-
ers will complete the information in the inclusion visit
and through the telephone interview.
There are some difficulties related to the measuring
instrument (telephone interview and face to face inter-
view), for ethical and legal reasons (consent form) as
well as validity (there are no valid surveys designed to
this effect). The researcher will carry out a pilot study
to rate the difficulties in completing the survey.
Only those health and medication problems more
often found in our field will be analysed in this study.
Alcohol intake and the consumption of psychoactive
substances will be considered self reported. Biological
tests will not be carried out because the objective is to
obtain the data under the same conditions of actual
clinical practice carried out in primary care visits.
The generalisation of the results will be limited to an
urban population.
Ethical aspects
The study will be carried out according to the principles
contained in the Helsinki Declaration and its successive
reviews and the Good Clinical Practice standards. The
LESIONAT study protocol obtained approval from the
corresponding Ethics Committee (CEIC IDIAP Jordi
Gol).
Consent form: the information will be provided verb-
ally and in writing. The study subjects will have suffi-
cient opportunity to ask about study details. Printing of
the consent form will follow the rules contained in the
Helsinki declaration as stipulated in article 12 under the
first title of the Royal Decree 15/1999.
Data confidentiality: in this study, only researchers and
monitors/auditors will have access to the information on
the participating subjects.
Discussion
There are various motives that justify the importance of
this study. Primary health care is an advantageous loca-
tion to carry out preventive interventions in RTI. In our
country, according to data provided by the Primary
Health Care Information System, 75% of the population
consults a general practitioner at least in their life, and
the average number of visits is between 5 and 6 yearly.
Furthermore, public health cover in Spain is practically
universal. This makes primary health care an ideal place
for the study and implementation of preventive mea-
sures in the RTI field. These could include warnings
from the side effects of certain medication, the effects of
psychoactive substances on driving skills to the impor-
tance of the control and monitoring of chronic or acute
illnesses that help the patient elaborate a real reception
of their physical state and capacity to drive [60-62].
RTI pose health problems that are extremely high in
magnitude and in social and health repercussions. The
Catalan Public Health Plan contemplates this interven-
tion as a priority objective, and so establishes the
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mortality rate associated with RTI in the main 3 popula-
tion groups where they are most frequent (see introduc-
tion). 2. To reduce by 50% the mortality rate associated
with RTI in men and women from 15 to 24 years old. 3.
To reduce by 50% the mortality rates associated with
RTI in drivers linked to an excessive intake of alcohol.
4. To reduce by 25% the prevalence of severe injuries
associated with RTI in the 3 main population groups
(see introduction).
The elements evaluated in this study (medication,
chronic health conditions, consumption of psychoactive
substances), are often managed in the Primary Care
field and are therefore registered in medical records.
Moreover, these are aspects that are inherently related
to the Primary Health Care field which means that the
date is quite complete and difficult to attain in other
existing registers.
The improvement in the basic knowledge of risk levels
of suffering from an RTI that this study aims to achieve
is a necessary first step for the definition of preventative
activities in primary health care in the near future.
The research team sets out the possibility of creating a
group with the population group, and establishing tele-
phone monitoring within it to investigate the prospec-
tive appearance of RTI, and the factors associated with
them. With this idea, the included subjects will be asked
for their consent, and to provide a contact phone num-
ber and a preferred time of day for posterior contact.
Regarding the bibliographic impact of this study and
after thoroughly reviewing the available bibliography, we
did not find any studies similar to the project that we
propose. Therefore, we believe that the originality of the
questions that we raise (taken from a primary health
care approach) provided added value.
Note
* “LESIONAT": Niveles de Riesgo de sufrir una LESION
por Accidente de Trafico en atención primaria”
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